All Stories

  1. Risk Factors for Mortality in Patients Treated with Colistin Monotherapy for Carbapenem-Resistant Acinetobacter baumannii Infections

    Article • Infectious Diseases and Clinical Microbiology, September 2025, Doc Design and Informatics Co. Ltd.

    Dr. Wasan Katip

  2. Decision-Making System for Extended Bacteremia Treatment in Patients with Hematologic Malignancy

    Article • INDONESIAN JOURNAL OF PHARMACY, March 2025, Universitas Gadjah Mada

    Dr. Wasan Katip

  3. Systematic review and meta‐analysis of vancomycin therapeutic level for treatment of vancomycin‐sensitive enterococcal infections

    Article • British Journal of Clinical Pharmacology, December 2024, Wiley

    Dr. Wasan Katip

  4. Comparative effectiveness and mortality of colistin monotherapy versus colistin-fosfomycin combination therapy for the treatment of carbapenem-resistant Enterobacteriaceae (CRE) infections: A propensity score analysis

    Article • Journal of Infection and Public Health, May 2024, Elsevier

    Dr. Wasan Katip

  5. High-Loading-Dose Colistin with Nebulized Administration for Carbapenem-Resistant Acinetobacter baumannii Pneumonia in Critically Ill Patients: A Retrospective Cohort Study

    Article • Antibiotics, March 2024, MDPI AG

    Dr. Wasan Katip

  6. Risk Factors for Acute Kidney Injury in Patients Receiving Intravenous Colistin

    Article • Pharmaceutical Sciences, January 2024, MaadRayan Publishing Company

    Dr. Wasan Katip

  7. Comparative stability of imipenem and meropenem solutions for extended infusion administration

    Article • Pharmaceutical Sciences Asia, January 2024, Faculty of Pharmacy, Mahidol University

    Dr. Wasan Katip

  8. Utilizing liposomal encapsulation approach to address nephrotoxic challenges of colistimethate sodium through a preclinical study

    Article • Frontiers in Pharmacology, November 2023, Frontiers

    Dr. Wasan Katip

  9. Comparative Safety and Effectiveness of Heterologous CoronaVac–ChAdOx1 versus Homologous CoronaVac Vaccination in a Real-World Setting: A Retrospective Cohort Study

    Article • Vaccines, September 2023, MDPI AG

    Dr. Wasan Katip

  10. Short versus long course of colistin treatment for carbapenem-resistant A. baumannii in critically ill patients: A propensity score matching study

    Article • Journal of Infection and Public Health, August 2023, Elsevier

    Dr. Wasan Katip

  11. Treatment costs for patients with Streptococcus suis infection in Northern Thailand: a hospital-based observational study of 14-year data

    Article • BMC Public Health, April 2023, Springer Science + Business Media

    Dr. Wasan Katip

  12. Predicting the Area under the Plasma Concentration-Time Curve (AUC) for First Dose Vancomycin Using First-Order Pharmacokinetic Equations

    Article • Antibiotics, March 2023, MDPI AG

    Dr. Wasan Katip

  13. Treatment Costs for Patients with Streptococcus suis infection in Northern Thailand: A Hospital-based Observational Study of 14-year data

    Article • November 2022, Research Square

    Dr. Wasan Katip

  14. Incidence of postpartum infections and outcomes associated with antibiotic prophylaxis after normal vaginal birth

    Article • Frontiers in Medicine, September 2022, Frontiers

    Dr. Wasan Katip, surapon nochaiwong

  15. Effectiveness and Nephrotoxicity of Loading Dose Colistin–Meropenem versus Loading Dose Colistin–Imipenem in the Treatment of Carbapenem-Resistant Acinetobacter baumannii Infection

    Article • Pharmaceutics, June 2022, MDPI AG

    Dr. Wasan Katip

  16. Factors Predicting Practices in Prevention of COVID-19 and Impacts among Population in Chiang Mai, Thailand

    Article • Medicina, April 2022, MDPI AG

    Dr. Wasan Katip

  17. The Thirty-Day Mortality Rate and Nephrotoxicity Associated With Trough Serum Vancomycin Concentrations During Treatment of Enterococcal Infections: A Propensity Score Matching Analysis

    Article • Frontiers in Pharmacology, January 2022, Frontiers

    Dr. Wasan Katip

  18. Clinical Efficacy and Nephrotoxicity of the Loading Dose Colistin for the Treatment of Carbapenem-Resistant Acinetobacter baumannii in Critically Ill Patients

    Article • Pharmaceutics, December 2021, MDPI AG

    Dr. Wasan Katip

  19. Influence of Concentration and Temperature on Stability of Imipenem Focused on Solutions for Extended Infusion

    Article • Dose-Response, October 2021, SAGE Publications

    Dr. Wasan Katip

  20. A Monocentric Retrospective Study of AUC/MIC Ratio of Vancomycin Associated with Clinical Outcomes and Nephrotoxicity in Patients with Enterococcal Infections

    Article • Pharmaceutics, August 2021, MDPI AG

    Dr. Wasan Katip

  21. Preclinical Evaluations of Modified Rice Hydrogel for Topical Ophthalmic Drug Delivery of Praziquantel on Avian Philophalmiasis

    Article • Pharmaceutics, June 2021, MDPI AG

    Dr. Wasan Katip

  22. Short-Course Versus Long-Course Colistin for Treatment of Carbapenem-Resistant A.baumannii in Cancer Patient

    Article • Antibiotics, April 2021, MDPI AG

    Dr. Wasan Katip

  23. Clinical Efficacy and Nephrotoxicity of Colistin Alone versus Colistin Plus Vancomycin in Critically Ill Patients Infected with Carbapenem-Resistant Acinetobacter baumannii: A Propensity Score-Matched Analysis

    Article • Pharmaceutics, January 2021, MDPI AG

    Dr. Wasan Katip

  24. Efficacy of loading dose colistin versus carbapenems for treatment of extended spectrum beta lactamase producing Enterobacteriaceae

    Article • Scientific Reports, January 2021, Springer Science + Business Media

    Dr. Wasan Katip

  25. Serotypes and Vaccine Coverage of Streptococcus Pneumoniae Colonization in the Nasopharynx of Thai Children in Congested Areas in Chiang Mai

    Article • Pathogens, November 2020, MDPI AG

    Dr. Wasan Katip

  26. A Comparison of Colistin versus Colistin Plus Meropenem for the Treatment of Carbapenem-Resistant Acinetobacter baumannii in Critically Ill Patients: A Propensity Score-Matched Analysis

    Article • Antibiotics, September 2020, MDPI AG

    Dr. Wasan Katip

  27. The effectiveness and nephrotoxicity of loading dose colistin combined with or without meropenem for the treatment of carbapenem-resistant A. baumannii

    Article • International Journal of Infectious Diseases, August 2020, Elsevier

    Dr. Wasan Katip

  28. Correlation of the vancomycin 24-h area under the concentration-time curve (AUC24) and trough serum concentration in children with severe infection: A clinical pharmacokinetic study

    Article • International Journal of Infectious Diseases, March 2020, Elsevier

    Dr. Wasan Katip

  29. A risk scoring system for predicting Streptococcus suis hearing loss: A 13-year retrospective cohort study

    Article • PLOS One, February 2020, PLOS

    Dr. Wasan Katip

  30. Phytochemical and Safety Evaluations of Volatile Terpenoids from Zingiber cassumunar Roxb. on Mature Carp Peripheral Blood Mononuclear Cells and Embryonic Zebrafish

    Article • Molecules, January 2020, MDPI AG

    Dr. Wasan Katip

  31. Clinical Manifestations and Risk Factors of Streptococcus suis Mortality Among Northern Thai Population: Retrospective 13-Year Cohort Study

    Article • Infection and Drug Resistance, December 2019, Taylor & Francis

    Dr. Wasan Katip

  32. 2126. Comparison of Time to Appropriate Antibiotic Between Using Microarray Assay and Mass Spectrometry Technique for Identification of Positive Blood Cultures

    Article • Open Forum Infectious Diseases, October 2019, Oxford University Press (OUP)

    Dr. Wasan Katip

  33. Endophthalmitis with bilateral deafness from disseminated Streptococcus suis infection

    Article • BMJ Case Reports, February 2019, BMJ

    Dr. Wasan Katip

  34. Factors associated with mortality in immunocompetent patients with hospital-acquired pneumonia

    Article • Journal of Global Infectious Diseases, January 2019, Medknow

    Dr. Wasan Katip

  35. Effects of an antimicrobial restriction system on appropriate carbapenem use in a hospital without infectious diseases consultation

    Article • International Journal of General Medicine, November 2017, Dove Medical Press

    Dr. Wasan Katip

  36. Clinical outcomes and nephrotoxicity of colistin loading dose for treatment of extensively drug-resistant Acinetobacter baumannii in cancer patients

    Article • Infection and Drug Resistance, September 2017, Dove Medical Press

    Dr. Wasan Katip

  37. Efficacy and Safety of High Loading Dose of Colistin in Multidrug-Resistant Acinetobacter baumannii: A Prospective Cohort Study

    Article • Journal of Intensive Care Medicine, August 2017, SAGE Publications

    Dr. Wasan Katip

  38. Visual compatibility of colistin injection with other antibiotics during simulated Y-site administration

    Article • American Journal of Health-System Pharmacy, July 2017, American Society of Health System Pharmacists

    Dr. Wasan Katip

  39. The pharmacokinetics of vancomycin during the initial loading dose in patients with septic shock

    Article • Infection and Drug Resistance, November 2016, Dove Medical Press

    Dr. Wasan Katip, Sutep Jaruratanasirikul

  40. DRESS syndrome caused by para-aminosalicylic acid: a case report and literature review

    Article • Asian Pacific Journal of Tropical Disease, March 2016, Elsevier

    Dr. Wasan Katip